Hims & Hers review: pricing, fine print, and how it ranks

The price, in words

Hims & Hers offers tirzepatide but publishes no price we could capture; we track it as unpriced rather than guessing. Hims & Hers fulfills brand-name medication (Wegovy, Zepbound, generic liraglutide), so your medication cost is the manufacturer's self-pay or your insurance copay, on top of any program fee shown above.

What the fine print says

Closed its compounded GLP-1 program to new patients in 2026 and has been brand-only for new starts since March 2026. Confirm at checkout whether the plan you are quoted is brand medication and what the all-in monthly comes to.

Pharmacy & transparency

Price evidence: No price published, last verified 2026-08-05. Pharmacy disclosure is a strength: brand fulfillment; compounded program closed to new patients — brand fulfillment.

Nearest alternatives at this price point

Shopping the immediate neighborhood, the closest verified substitutes are NexLife at $215 (flat at every dose, no membership, named pharmacy); Yucca Health at $258 (flat at every dose, no membership, prepaid to $225); IVIM Health at $278 (source-verified) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Hims & Hers publishes availability of: 50 states. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the current all-in monthly price, in writing, since no verifiable figure is published; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) confirmation that fulfillment still runs through its named network (brand fulfillment; compounded program closed to new patients) for your state; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit Hims & Hers — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

Hims & Hers's value case is brand-name product and (where offered) insurance navigation rather than the cheapest cash rate. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.